Ames MM - Search Results

1

Pharmacokinetics of 3-methyl-(triazen-1-yl)imidazole-4-carboximide following administration of temozolomide to patients with advanced cancer.

Reid JM, Stevens DC, Rubin J, Ames MM. Reid JM, et al. Among authors: ames mm. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2393-8. Clin Cancer Res. 1997. PMID: 9815639 Clinical Trial.

2

Plasma pharmacokinetics and cerebrospinal fluid concentrations of idarubicin and idarubicinol in pediatric leukemia patients: a Childrens Cancer Study Group report.

Reid JM, Pendergrass TW, Krailo MD, Hammond GD, Ames MM. Reid JM, et al. Among authors: ames mm. Cancer Res. 1990 Oct 15;50(20):6525-8. Cancer Res. 1990. PMID: 2208112 Clinical Trial.

3

Preclinical pharmacology of bizelesin, a potent bifunctional analog of the DNA-binding antibiotic CC-1065.

Walker DL, Reid JM, Ames MM. Walker DL, et al. Among authors: ames mm. Cancer Chemother Pharmacol. 1994;34(4):317-22. doi: 10.1007/BF00686039. Cancer Chemother Pharmacol. 1994. PMID: 8033298

4

Preclinical pharmacology of ecteinascidin 729, a marine natural product with potent antitumor activity.

Reid JM, Walker DL, Ames MM. Reid JM, et al. Among authors: ames mm. Cancer Chemother Pharmacol. 1996;38(4):329-34. doi: 10.1007/s002800050491. Cancer Chemother Pharmacol. 1996. PMID: 8674155

5

Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II.

Adjei AA, Charron M, Rowinsky EK, Svingen PA, Miller J, Reid JM, Sebolt-Leopold J, Ames MM, Kaufmann SH. Adjei AA, et al. Among authors: ames mm. Clin Cancer Res. 1998 Mar;4(3):683-91. Clin Cancer Res. 1998. PMID: 9533538

6

Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks.

Alberts SR, Erlichman C, Reid JM, Sloan JA, Ames MM, Richardson RL, Goldberg RM. Alberts SR, et al. Among authors: ames mm. Clin Cancer Res. 1998 Sep;4(9):2111-7. Clin Cancer Res. 1998. PMID: 9748127 Clinical Trial.

7

Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins.

Lawrence JB, Conover CA, Haddad TC, Ingle JN, Reid JM, Ames MM, Suman VJ, Marks RS, Erlichman C, Hartmann LC. Lawrence JB, et al. Among authors: ames mm. Clin Cancer Res. 1997 Oct;3(10):1713-20. Clin Cancer Res. 1997. PMID: 9815555 Clinical Trial.

8

Phase I and pharmacological trial of fazarabine (Ara-AC) with granulocyte colony-stimulating factor.

Goldberg RM, Reid JM, Ames MM, Sloan JA, Rubin J, Erlichman C, Kuffel MJ, Fitch TR. Goldberg RM, et al. Among authors: ames mm. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2363-70. Clin Cancer Res. 1997. PMID: 9815635 Clinical Trial.

9

Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer.

Dhodapkar M, Rubin J, Reid JM, Burch PA, Pitot HC, Buckner JC, Ames MM, Suman VJ. Dhodapkar M, et al. Among authors: ames mm. Clin Cancer Res. 1997 Jul;3(7):1093-100. Clin Cancer Res. 1997. PMID: 9815788 Clinical Trial.

10

Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors.

Pitot HC, McElroy EA Jr, Reid JM, Windebank AJ, Sloan JA, Erlichman C, Bagniewski PG, Walker DL, Rubin J, Goldberg RM, Adjei AA, Ames MM. Pitot HC, et al. Among authors: ames mm. Clin Cancer Res. 1999 Mar;5(3):525-31. Clin Cancer Res. 1999. PMID: 10100703 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters